ANTONIO ARTURO LOAEZA BREAKWELL
Medical Affairs Executive
Mexico City
Summary
Accomplished medical executive with over two decades of experience in leading medical affairs, clinical development, and regulatory compliance within the pharmaceutical industry. Demonstrated expertise in strategic planning, stakeholder engagement, change management, and team leadership. Successfully managed large teams, drove global initiatives, facilitated cross-functional collaborations, and delivered impactful results in fast-paced and complex environments.
Persistent leader eager to lead and grow organizations. Skilled in strategic planning, problem-solving, and communication with good understanding of business principles, project management and team leadership. Collaborative with relentless work ethic.
Pragmatic professional with solid experience in leadership roles. Adept at implementing strategic business plans, driving growth and improving operations. Skilled in financial management and stakeholder relations. Collaborative and dedicated to building and leading talented and motivated individuals.
Overview
24
24
years of professional experience
6
6
years of post-secondary education
Work History
Country Medical Chair / Country Medical Lead Speciality Care
Sanofi
Mexico City
6 2019 - Current
- Led global medical affair transformation project as part of two LATAM representatives within global team, enhancing global medical alignment
- Launched MedVox, first in-country digital MSL engagement platform, improving stakeholder interaction by 30%
- Pioneered implementation of simplification initiatives, guiding/ leading MedExc Manager, refining HCP engagement and diagnosis,
- Successfully led SEC audit with zero major findings
- Managed and developed team of over 40 FTEs, promoting key members to senior positions
- Effectively negotiated inclusion of SPC products into National formulary.
- Fostered relationships with stakeholders, promoting collaboration and partnership opportunities.
- Maintained impartiality and objectivity during meetings and decision-making.
- Streamlined decision-making processes for increased efficiency and productivity within organization.
- Fostered culture of inclusivity and open dialogue through regular team-building activities.
- Fostered collaboration across departments to streamline project implementation and enhance outcomes.
- Mentored new board members, providing guidance on roles, responsibilities, and expectations of position.
- Developed long-term strategic plans to guide organizational growth and success.
- Reduced attrition rate in complex environment
- Employee satisfaction thorough company survey showed high level of commitment from medical team members and high levels of satisfaction, with improvements year over year
Country Medical Chair / Country Medical Director Pharma
Sanofi
Mexico City
01.2018 - 06.2019
- Orchestrated integra,on of GenMed and SPC medical affairs teams, improving efficiency by 20%
- Acted as spokesperson during COVID-19 pandemic, implementing strategies that minimized hydroxychloroquine misuse by 40%
- Strengthened KOL relationships, increasing stakeholder involvement by 15%
- Ensured business continuity during significant organizational restructuring, maintaining 95% team retention rate.
- Maintained impartiality and objectivity during meetings and decision-making.
- Cultivated company-wide culture of innovation and collaboration.
- Created succession plans to provide continuity of operations during leadership transitions.
- Collaborated with legal, accounting and other professional teams to review and maintain compliance with regulations.
- Analyzed industry trends and tracked competitor activities to inform decision making.
Medical Director / Medical Head - Rare Diseases, Immunology, Oncology, Renal, and MulJple Sclerosis
Sanofi Genzyme
Mexico City
08.2014 - 01.2018
- Provided comprehensive medical guidance, boosting cross-functional collaboration by 20%
- Drove significant improvement in achievement of goals related to team/ employee relations.
- Streamlined approval processes with COFEPRIS, reducing ,me-to-market by 3 months
- Enhanced investigator engagement, increasing study participation rates by 35%
- Achieved a 100% compliance rate in pharmacovigilance audits.
- Led diverse team of medical and administrative professionals in day-to-day activities aligned to each annual brand plans, incorporating patient centricity projects, data driven initiatives, new business development, and internal and external stakeholder relations.
- Drove planning for business development and relationship building with healthcare partners.
- Collaborated with stakeholders to develop comprehensive medical programs addressing community needs.
- Represented staff at meetings and on designated committees relative to areas of specialty or service.
Senior Medical Manager for Neuroscience & Lysosomal Storage Diseases
Genzyme/ Genzyme, a Sanofi Company
Mexico City
11.2007 - 08.2014
- Prepared launch dossiers, resulting in a 15% increase in market adoption rates
- Achieved significant cost savings, reducing diagnostic costs by 70%
- Fostered effective collaboration, ensuring cohesive strategy and execution.
- Spearheaded initiatives that increased patient satisfaction scores while maintaining a high level of compliance of PSP activities and initiatives.
- Identified opportunities for growth through targeted market analysis, enabling expansion into new service lines or geographic regions.
Medical Manager for Infectology and Ophthalmology
Pfizer
Mexico City
06.2006 - 11.2007
- Developed and implemented marke,ng strategies, ensuring compliance and relevance
- Planned CME ac,vi,es and training sessions, enhancing sales representative knowledge
- Built and maintained strong relationships with KOLs, supporting product positioning.
- Directed staff training sessions on relevant topics such as new treatment protocols or regulatory updates to ensure consistent application of best practices throughout organization''s medical management efforts.
- Oversaw risk management activities within organization, mitigating potential issues related to patient safety or liability concerns.
- Implemented data-driven decision-making processes in medical management, leading to more accurate diagnoses and better patient outcomes.
Medical Market Liaisons Scienst (Cardio Portfolio)
Pfizer
01.2005 - 06.2006
- Kept KOLs informed on medical product informa,on, reinforcing key messages and strategies
- Relayed KOL feedback to marke,ng and sales teams, strengthening strategic alignment.
- Leveraged advanced statistical methods to analyze large datasets from clinical trials, unveiling hidden patterns or trends that could inform future study designs or interventions strategies.
- Conducted detailed literature reviews on relevant topics as part of ongoing professional development initiatives aimed at staying current within the field.
- Stayed current on industry advancements, attending relevant workshops and training sessions as needed.
Medical Doctor
George Eliot Hospital
01.2003 - 01.2004
- Assisted sub-specialists in the Diabetes clinic, ensuring high-quality patient care and follow-up in the Out-patient department
- Increased patient satisfaction with thorough assessments, clear communication, and empathetic bedside manner.
- Diagnosed and treated patients suffering from chronic conditions.
Assistant to the Director for the NaJonal HIV/AIDS and Other STD's Surveillance Program
Ministry of Health, Epidemiological Surveillance Office
01.2001 - 01.2003
- Coordinated public health strategies and resources for HIV/AIDS and other STD surveillance
- Provided detailed public health informa,on for strategic decision-making.
- Maintained strict confidentiality when handling sensitive information pertaining to company operations or personnel matters.
- Assisted in the preparation of presentations and reports, contributing to the successful delivery of information to stakeholders.
Education
Medical Affairs in Medicines Development and Professional Certification in Medicines Development (CMD) - Medicine
International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP) And King's College
London, EnglandDiploma in Organizational LEADer Program - Organizational Leadership
Harvard Business Publishing
Boston; USADiploma in Sanitary Regulation in the Pharmaceutical Industry - undefined
INEDUFARM/ Universidad Intercontinental
Diploma in Pharmaceutical Administration -
Instituto Tecnológico Y De Estudios Superiores De Monterrey
05.2001 - 01.2007
Master of Science in Applied Health Studies and Diabetes - undefined
Warwick University, Medical School
Diploma in Applied Epidemiology - undefined
UNAM/Secretaría de Salud
Medical Degree - undefined
La Salle University, Mexican School of Medicine
ACLS and BLS Certification - undefined
Hospital Santelena
First Certificate in English - undefined
The British Council
Skills
Strategic leadership
Personal Information
- Date of Birth: 03/10/73
- Nationality: Mexican and British
Languages
English
Bilingual or Proficient (C2)
Spanish
Bilingual or Proficient (C2)
Awards
VP Award 2010 for outstanding performance
Publications
- Fabry's disease: New concepts about its natural history, evolution and treatment, Revista de Nefrologia, Dialisis y Trasplante, 2009
- Reporte de 2 Nuevas Mutaciones en un Paciente Mexicano con Enfermedad de Pompe Infantil, 2nd Latin-American Symposium of Pompe Disease, Buenos Aires, Argentina, 2010
Timeline
Country Medical Chair / Country Medical Director Pharma
Sanofi
01.2018 - 06.2019
Medical Director / Medical Head - Rare Diseases, Immunology, Oncology, Renal, and MulJple Sclerosis
Sanofi Genzyme
08.2014 - 01.2018
Senior Medical Manager for Neuroscience & Lysosomal Storage Diseases
Genzyme/ Genzyme, a Sanofi Company
11.2007 - 08.2014
Medical Manager for Infectology and Ophthalmology
Pfizer
06.2006 - 11.2007
Medical Market Liaisons Scienst (Cardio Portfolio)
Pfizer
01.2005 - 06.2006
Medical Doctor
George Eliot Hospital
01.2003 - 01.2004
Diploma in Pharmaceutical Administration -
Instituto Tecnológico Y De Estudios Superiores De Monterrey
05.2001 - 01.2007
Assistant to the Director for the NaJonal HIV/AIDS and Other STD's Surveillance Program
Ministry of Health, Epidemiological Surveillance Office
01.2001 - 01.2003
Country Medical Chair / Country Medical Lead Speciality Care
Sanofi
6 2019 - Current
Medical Affairs in Medicines Development and Professional Certification in Medicines Development (CMD) - Medicine
International Federation of Associations of Pharmaceutical Physicians & Pharmaceutical Medicine (IFAPP) And King's College
Diploma in Organizational LEADer Program - Organizational Leadership
Harvard Business Publishing
Diploma in Sanitary Regulation in the Pharmaceutical Industry - undefined
INEDUFARM/ Universidad Intercontinental
Master of Science in Applied Health Studies and Diabetes - undefined
Warwick University, Medical School
Diploma in Applied Epidemiology - undefined
UNAM/Secretaría de Salud
Medical Degree - undefined
La Salle University, Mexican School of Medicine
ACLS and BLS Certification - undefined
Hospital Santelena
First Certificate in English - undefined
The British Council
Similar Profiles
Albin AugustyAlbin Augusty
Chemical Technician II at SanofiChemical Technician II at Sanofi
Rasmitrashini (Razy) Senthil KumarRasmitrashini (Razy) Senthil Kumar
Quality Control Intern (INTRA Placement) at SanofiQuality Control Intern (INTRA Placement) at Sanofi
Jalal DankarJalal Dankar
Business Analyst and Controller at SanofiBusiness Analyst and Controller at Sanofi
Richard J. VillaniRichard J. Villani
Associate Director, Operations & Demand Management at SANOFIAssociate Director, Operations & Demand Management at SANOFI
MARIANA REYNA FABIANMARIANA REYNA FABIAN
Oceans and Fisheries Scientist at OCEANA MexicoOceans and Fisheries Scientist at OCEANA Mexico